Actively Recruiting
Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial
Led by Oman Ministry of Health · Updated on 2026-03-30
138
Participants Needed
1
Research Sites
35 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the effectiveness of 4mg and 8mg dexamethasone administered submucosally in reducing postoperative pain after dental implant surgery. Participants will be randomly assigned to receive either 4mg dexamethasone, 8mg dexamethasone, or a placebo (normal saline) at the surgical site. Later, postoperative pain will be assessed using a Visual Analog Scale at 6 hours after the surgery and daily for the next 6 days. Also the number of pain-relief tablets consumed after the surgery will be recorded. Preoperative anxiety will be assessed using Generalized Anxiety Disorder-7 (GAD-7) questionnaire to assess its association with postoperative pain scores. The results of this study will help determine the optimal dose of dexamethasone that is effective for postoperative pain control following dental implant surgery.
CONDITIONS
Official Title
Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females
- Age between 21 and 80 years
- ASA I or II classification according to American Society of Anesthesiologists
- Scheduled for single tooth implant
- Implant placement timing of type 3 or type 4 (Chen and Buser, 2009)
You will not qualify if you...
- Allergy to any medications used in the study
- Current smoker or alcoholic
- Pregnant or breastfeeding women
- Need for bone augmentation or sinus lifting during surgery
- Requirement for antibiotic prophylaxis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al Nahdha Hospital
Muscat, Oman
Actively Recruiting
Research Team
S
Shurooq Slim Al Hinai, BDS
CONTACT
N
Nasser Al Khaldi, Senior Consultant Prosth
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here